Saeed Dabestani

Lund University

Papers

1

Total Citations

8

H-Index

1

About

Saeed Dabestani is a leading urologic oncologist whose research focuses on renal cell carcinoma (RCC), particularly its recurrence patterns and long-term management. His major contribution lies in elucidating the natural history of localized RCC through the landmark European multicenter RECUR database study, which analyzed recurrence patterns in over 2,000 patients. This work, cited 8 times, provides critical insights into the timing and sites of disease relapse, directly informing surveillance protocols and postoperative care strategies. Dabestani’s research bridges clinical practice and evidence-based guidelines, helping to refine risk stratification for RCC patients. Beyond this, he has contributed to European Association of Urology guidelines on kidney cancer, shaping international standards. His impact is reflected in his role as a key collaborator in large-scale, multi-institutional projects that generate real-world data, advancing precision medicine in urologic oncology. For students and researchers, Dabestani exemplifies how rigorous, collaborative registry studies can transform clinical decision-making and improve outcomes for cancer patients.

Research Focus

Key Achievements

1
H-Index
1
Papers
8
Total Citations
8
Avg Citations/Paper
🏆 Most Cited Paper
Recurrence pattern in localized RCC: results from a European multicenter database (RECUR)
8 citations · 2022
📈 Most Prolific Year: 2022 (1 Papers)
🤝 Key Collaborators: 20
🏛 Institutions: Lund University

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago